ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 171 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $845 | +0.6% | 170 | 0.0% | 0.00% | – |
| Q1 2023 | $840 | -100.0% | 170 | -99.9% | 0.00% | -100.0% |
| Q4 2022 | $1,722,535 | +172153.5% | 273,853 | +636767.4% | 0.01% | – |
| Q3 2022 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -99.8% | 43 | -99.9% | 0.00% | -100.0% |
| Q1 2022 | $535,000 | +32.1% | 58,693 | +265.8% | 0.00% | 0.0% |
| Q4 2020 | $405,000 | -87.2% | 16,044 | -80.9% | 0.00% | -85.7% |
| Q3 2020 | $3,171,000 | -37.1% | 84,088 | -28.6% | 0.01% | -41.7% |
| Q2 2020 | $5,040,000 | -0.4% | 117,707 | -32.7% | 0.01% | -7.7% |
| Q1 2019 | $5,059,000 | +7.3% | 175,000 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $4,713,000 | – | 175,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |